Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.

Guide · Regulation · United States

Are peptides legal in the US? The FDA status of each peptide

It depends on the peptide. A few are FDA-approved prescription medicines. Six may now be compounded on a prescription under an interim HHS policy that is not an FDA approval. Most others sold online have no FDA-approved product and no legal route as a medicine. The tables below give the status of each peptide we cover, with the official record behind it, so you can check it yourself.

What changed in 2026

  • In 2023 the FDA restricted compounding of BPC-157 and a group of other peptides over safety concerns.
  • In April 2026 BPC-157 was removed from the FDA's restricted 503A compounding list.
  • In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend six peptides for compounding, despite FDA staff advising against it.
  • On October 28, 2026 the HHS Office of the Secretary announced an interim policy of enforcement discretion for compounding those six peptides under section 503A, published in the Federal Register on October 30, 2026 (Docket No. HHS-OASH-2026-0496).

Sources: Time, "The Peptide Rush Has Begun", October 28, 2026; Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (Docket HHS-OASH-2026-0496), Federal Register public inspection copy.

FDA-approved peptide medicines

These have at least one FDA-approved product. Each approval is for specific uses, and every one needs a prescription.

FDA-approved peptide medicines
PeptideUS statusOfficial record
SemaglutideFDA approved as Ozempic for type 2 diabetes (2017) and as Wegovy for chronic weight management (2021). Compounded copies are not FDA approved.
TirzepatideFDA approved as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023). Compounded copies are not FDA approved.
LiraglutideFDA approved as Victoza for type 2 diabetes (2010) and as Saxenda for chronic weight management (2014). A generic was first approved in 2024.
TesamorelinFDA approved as Egrifta (2010) only to reduce excess abdominal fat in adults with HIV and lipodystrophy.
SS-31 (elamipretide)FDA approved as Forzinity (September 2025) under accelerated approval, only to improve muscle strength in Barth syndrome.
SermorelinWas FDA approved as Geref (1990 and 1997); both products were discontinued, and the FDA determined in 2013 they were not withdrawn for reasons of safety or effectiveness. US telehealth programs prescribe compounded sermorelin, which is not FDA approved.

Covered by the HHS interim compounding policy (October 2026)

No FDA-approved product exists for these six. Since October 2026 an interim HHS policy lets licensed 503A pharmacies compound them on a patient-specific prescription, by the route listed. HHS says the policy does not grant FDA approval or establish safety and effectiveness, and that it may revisit it.

Covered by the HHS interim compounding policy (October 2026)
PeptideUS statusOfficial record
BPC-157No FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: subcutaneous, intramuscular, oral or topical.
TB-500No FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: subcutaneous or intramuscular injection.
MOTS-cNo FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: subcutaneous or intramuscular injection.
KPVNo FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: topical or oral only.
SemaxNo FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: intranasal only.
EpitalonNo FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: injection, dispensed in intermittent courses.

No FDA-approved product and not covered by the policy

None of these has an FDA-approved product, and none is one of the six peptides in the HHS interim policy.

No FDA-approved product and not covered by the policy
PeptideUS statusOfficial record
RetatrutideInvestigational. No FDA-approved product; Eli Lilly has said it plans to submit it to the FDA. Products sold online as retatrutide are not approved medicines.
Cagrilintide (CagriSema)No FDA-approved product. Novo Nordisk has filed CagriSema (cagrilintide with semaglutide) with the FDA; it is not approved.
SurvodutideInvestigational. No FDA-approved product.
CJC-1295No FDA-approved product.
IpamorelinNo FDA-approved product.
AOD-9604No FDA-approved product.
Thymosin alpha-1No FDA-approved product.
SelankNo FDA-approved product.
GHK-CuNo FDA-approved drug product.
DSIPNo FDA-approved product.

Where to go from here

Frequently asked questions

Are peptides legal in the US?

Some are FDA-approved prescription medicines, such as semaglutide, tirzepatide and liraglutide. Six others (BPC-157, TB-500, MOTS-c, KPV, Semax and Epitalon) may be compounded by licensed 503A pharmacies on a prescription under an interim HHS policy published on October 30, 2026, which is not an FDA approval. Most other peptides sold online have no FDA-approved product and no legal route as a medicine.

What peptides are FDA approved?

Among the peptides we cover: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), tesamorelin (Egrifta, for HIV-associated abdominal fat) and elamipretide, sold as Forzinity for Barth syndrome. Sermorelin was approved as Geref, but both Geref products were discontinued.

Is BPC-157 legal now?

BPC-157 has no FDA-approved product. Since the HHS interim policy of October 2026, a licensed 503A pharmacy may compound it on a patient-specific prescription by the routes the policy lists. Products sold online for "research use" are not covered by the policy.

Is sermorelin FDA approved?

Sermorelin was FDA approved as Geref, in 1990 and 1997, and both products were later discontinued; the FDA determined in 2013 that they were not withdrawn for reasons of safety or effectiveness. US telehealth programs prescribe compounded sermorelin, which is not FDA approved.

Is retatrutide legal?

Retatrutide is investigational and has no FDA-approved product, and it is not one of the six peptides in the HHS interim policy. Eli Lilly has said it plans to submit it to the FDA. Products sold online as retatrutide are not approved medicines.

This page is information, not legal or medical advice. Rules can change; each status links to the record it rests on and the date it was read. It recommends no peptide and gives no dosing guidance.